SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043416
Filing Date
2021-08-11
Accepted
2021-08-11 16:01:17
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q scph-10q_20210630.htm   iXBRL 10-Q 1818399
2 EX-31.1 scph-ex311_7.htm EX-31.1 11063
3 EX-32.1 scph-ex321_6.htm EX-32.1 8144
  Complete submission text file 0001564590-21-043416.txt   7242767

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA scph-20210630.xsd EX-101.SCH 47252
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scph-20210630_cal.xml EX-101.CAL 51015
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scph-20210630_def.xml EX-101.DEF 134342
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20210630_lab.xml EX-101.LAB 380971
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20210630_pre.xml EX-101.PRE 290695
9 EXTRACTED XBRL INSTANCE DOCUMENT scph-10q_20210630_htm.xml XML 1504628
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38293 | Film No.: 211163306
SIC: 2834 Pharmaceutical Preparations